Thus, the role of GLI1 for the proliferation of ERα-positive breast cancer cells may be exploited for therapeutic purposes, and drug targeting of GLI1 could enhance the tamoxifen efficacy in the treatment of breast cancer. Here, ESR1 is linked to breast cancer.